会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 2. 发明申请
    • FERRITIN-BASED TUMOR TARGETING AGENT, AND IMAGING AND TREATMENT METHODS
    • 基于FERRITIN的肿瘤靶向剂,成像和治疗方法
    • US20150224212A1
    • 2015-08-13
    • US14626071
    • 2015-02-19
    • Brown UniversityRhode Island Hospital
    • William Keun Chan ParkDavid R. MillsEdward G. Walsh
    • A61K49/18G01N33/574
    • A61K49/1875C07K16/2896G01N33/57492G01N33/57496G01N2333/47
    • An MRI contrast material includes tumor-targeting metal-loaded ferritin nanoparticles constructed with genetically modified ferritin coupled to a target-specific agent. Ferritin derived from Archaeoglobus flulgidus (AfFtn-AA) forms hollow nanocages surrounding paramagnetic or superparamagnetic metal core, storing a significantly greater quantity of iron (approximately 7,000 Fe ions per ferritin cage) or other paramagnetic or superparamagnetic metal than natural ferritins, and is conjugated via a short linker with a monoclonal antibody against a cell surface antigen overexpressed by a cancer, to selectively and efficiently attach to tumor cells to enhance MRI contrast. Significant T2 contrast with diminished T1 effect was observed owing to the heterogeneous nanoconjugate distribution when bound to cells. In a treatment method, after imaging, an external stimulus heats the cell-bound agent to release the metal and selectively destroy the targeted cells. The enhanced imaging and release of toxic metal ions provides simultaneous early detection and treatment.
    • MRI造影材料包括用与靶特异性试剂偶联的遗传修饰的铁蛋白构建的肿瘤靶向金属负载的铁蛋白纳米颗粒。 衍生自弓形虫(AfFtn-AA)的铁蛋白形成围绕顺磁性或超顺磁性金属核心的中空纳米笼,与天然铁蛋白相比,存储显着更多量的铁(每个铁蛋白笼约7,000个Fe离子)或其他顺磁性或超顺磁性金属, 具有针对由癌细胞过度表达的细胞表面抗原的单克隆抗体的短接头,选择性且有效地附着于肿瘤细胞以增强MRI对比度。 当与细胞结合时,由于异质纳米缀合物分布,观察到T1效应降低的显着T2对比。 在处理方法中,在成像之后,外部刺激加热细胞结合剂以释放金属并选择性地破坏靶细胞。 有毒金属离子的增强成像和释放提供同时的早期检测和处理。